Cargando…

Metronidazole for the treatment ofTritrichomonas foetusin bulls

BACKGROUND: Tritrichomonas foetus is a sexually transmitted protozoon that causes reproductive failure, among cattle, so disruptive that many western US states have initiated control programs. Current control programs are based on the testing and exclusion of individual bulls. Unfortunately, these p...

Descripción completa

Detalles Bibliográficos
Autores principales: Love, David, Fajt, Virginia R., Hairgrove, Thomas, Jones, Meredyth, Thompson, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391598/
https://www.ncbi.nlm.nih.gov/pubmed/28410582
http://dx.doi.org/10.1186/s12917-017-0999-2
_version_ 1783229307012775936
author Love, David
Fajt, Virginia R.
Hairgrove, Thomas
Jones, Meredyth
Thompson, James A.
author_facet Love, David
Fajt, Virginia R.
Hairgrove, Thomas
Jones, Meredyth
Thompson, James A.
author_sort Love, David
collection PubMed
description BACKGROUND: Tritrichomonas foetus is a sexually transmitted protozoon that causes reproductive failure, among cattle, so disruptive that many western US states have initiated control programs. Current control programs are based on the testing and exclusion of individual bulls. Unfortunately, these programs are utilizing screening tests that are lacking in sensitivity. Blanket treatment of all the exposed bulls and adequate sexual rest for the exposed cows could provide a more viable disease control option. The objectives of this study were twofold. The first objective was to demonstrate effectiveness for metronidazole treatment of a bull under ideal conditions and with an optimized treatment regime. This type of study with a single subject is often referred to as an n-of-1 or single subject clinical trial. The second objective of the current study was to review the scientific basis for the banning of metronidazole for use in Food Animals by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). RESULTS: Results from an antimicrobial assay indicated that metronidazole at a concentration of 0.5 μg/mL successfully eliminated in vitro protozoal growth of bovine Tritrichomonas foetus. The estimated effective intravenous dose was two treatments with 60 mg/kg metronidazole, 24 h apart. A bull that had tested positive for Tritrichomonas foetus culture at weekly intervals for 5 weeks prior to treatment was negative for Tritrichomonas foetus culture at weekly intervals for five consecutive weeks following this treatment regimen. An objective evaluation of the published evidence on the potential public health significance of using metronidazole to treat Tritrichomonas foetus in bulls provides encouragement for veterinarians and regulators to consider approaches that might lead to permitting the legal use of metronidazole in bulls. CONCLUSION: The study demonstrated successful inhibition of Tritrichomonas foetus both in vitro and in vivo with metronidazole. The current status of metronidazole is that the Animal Medicinal Drug Use Clarification Act of 1994 prohibits its extra-label use in food-producing animals. Veterinarians and regulators should consider approaches that might lead to permitting the legal use of metronidazole in bulls.
format Online
Article
Text
id pubmed-5391598
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53915982017-04-17 Metronidazole for the treatment ofTritrichomonas foetusin bulls Love, David Fajt, Virginia R. Hairgrove, Thomas Jones, Meredyth Thompson, James A. BMC Vet Res Research Article BACKGROUND: Tritrichomonas foetus is a sexually transmitted protozoon that causes reproductive failure, among cattle, so disruptive that many western US states have initiated control programs. Current control programs are based on the testing and exclusion of individual bulls. Unfortunately, these programs are utilizing screening tests that are lacking in sensitivity. Blanket treatment of all the exposed bulls and adequate sexual rest for the exposed cows could provide a more viable disease control option. The objectives of this study were twofold. The first objective was to demonstrate effectiveness for metronidazole treatment of a bull under ideal conditions and with an optimized treatment regime. This type of study with a single subject is often referred to as an n-of-1 or single subject clinical trial. The second objective of the current study was to review the scientific basis for the banning of metronidazole for use in Food Animals by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). RESULTS: Results from an antimicrobial assay indicated that metronidazole at a concentration of 0.5 μg/mL successfully eliminated in vitro protozoal growth of bovine Tritrichomonas foetus. The estimated effective intravenous dose was two treatments with 60 mg/kg metronidazole, 24 h apart. A bull that had tested positive for Tritrichomonas foetus culture at weekly intervals for 5 weeks prior to treatment was negative for Tritrichomonas foetus culture at weekly intervals for five consecutive weeks following this treatment regimen. An objective evaluation of the published evidence on the potential public health significance of using metronidazole to treat Tritrichomonas foetus in bulls provides encouragement for veterinarians and regulators to consider approaches that might lead to permitting the legal use of metronidazole in bulls. CONCLUSION: The study demonstrated successful inhibition of Tritrichomonas foetus both in vitro and in vivo with metronidazole. The current status of metronidazole is that the Animal Medicinal Drug Use Clarification Act of 1994 prohibits its extra-label use in food-producing animals. Veterinarians and regulators should consider approaches that might lead to permitting the legal use of metronidazole in bulls. BioMed Central 2017-04-14 /pmc/articles/PMC5391598/ /pubmed/28410582 http://dx.doi.org/10.1186/s12917-017-0999-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Love, David
Fajt, Virginia R.
Hairgrove, Thomas
Jones, Meredyth
Thompson, James A.
Metronidazole for the treatment ofTritrichomonas foetusin bulls
title Metronidazole for the treatment ofTritrichomonas foetusin bulls
title_full Metronidazole for the treatment ofTritrichomonas foetusin bulls
title_fullStr Metronidazole for the treatment ofTritrichomonas foetusin bulls
title_full_unstemmed Metronidazole for the treatment ofTritrichomonas foetusin bulls
title_short Metronidazole for the treatment ofTritrichomonas foetusin bulls
title_sort metronidazole for the treatment oftritrichomonas foetusin bulls
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391598/
https://www.ncbi.nlm.nih.gov/pubmed/28410582
http://dx.doi.org/10.1186/s12917-017-0999-2
work_keys_str_mv AT lovedavid metronidazoleforthetreatmentoftritrichomonasfoetusinbulls
AT fajtvirginiar metronidazoleforthetreatmentoftritrichomonasfoetusinbulls
AT hairgrovethomas metronidazoleforthetreatmentoftritrichomonasfoetusinbulls
AT jonesmeredyth metronidazoleforthetreatmentoftritrichomonasfoetusinbulls
AT thompsonjamesa metronidazoleforthetreatmentoftritrichomonasfoetusinbulls